Table 1.
Patient demographics, disease indices, tobacco use, HLA-SE categories and autoantibody positivity rates in the group of RA patients
| n=75 | N (%) | Median iqr | (min-max) |
| Age(years) | 47.8 19 | (18 –75) | |
| Females | 61 (81) | ||
| Males | 14 (19) | ||
| Disease Duration (months) | 8.5 11.9 | (2 –25) | |
| <6 months | 24 (32) | ||
| 6 to 12 months | 27 (36) | ||
| >12 months | 24 (32) | ||
| SDAI | 40 25 | (5 –76) | |
| LDA, n(%) | 2 (3) | ||
| MDA, n(%) | 17 (23) | ||
| HDA, n(%) | 56 (75) | ||
| X-ray Score | 1913 | (1–48) | |
| Erosions, n(%) | 31 (47) | ||
| Tobacco use | 28 (37) | ||
| HLA-SE | 71 (95) | ||
| Homozygous | 41 (55) | ||
| Heterozygous | 30 (40) | ||
| hs-CRP(mg/dl) | 13 22 | (1 –113) | |
| RF(UI/ml) | 161 403 | (4 –1720) | |
| RF positivity | 65 (87) | ||
| RF-IgA (IU/ml) | 4154 | (3–436) | |
| RF positivity | 66 (88) | ||
| ACPA(U/ml) | 494839 | (2 –1621) | |
| ACPA positivity | 65 (88) | ||
| ACPA-IgA(U/ml) | 1122 | (1–87) | |
| ACPA-IgA positivity | 23 (31) | ||